Pete de Spain
Investor Relations Contact at KURA ONCOLOGY, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Troy Wilson | M | 55 | 10 years | |
| David Urso | M | 60 | 10 years | |
| Charles Baltic | M | 63 | 13 years | |
| Teresa Bair | F | 53 | 3 years | |
| Helen Collins | M | 62 | 3 years | |
| Diane Parks | F | 71 | 5 years | |
| Carol Schafer | F | 60 | 3 years | |
| Thomas Doyle | M | 53 | 3 years | |
| Nick Glover | M | 55 | 11 years | |
| Mary Szela | F | 60 | 6 years | |
| Thomas Malley | M | 55 | 9 years | |
| Thomas Reynolds | M | 65 | 11 years | |
| Faheem Hasnain | M | 65 | 9 years | |
| Kathleen Ford | F | 77 | 5 years | |
| Mollie Leoni | M | - | 4 years | |
| Stephen Dale | M | 52 | 4 years | |
| Brian Powl | M | 50 | 1 years | |
| Richard Ghalie | M | 66 | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hubert Köster | M | - | 4 years | |
| Antonius P. Schuh | M | 59 | 5 years | |
| Marc Grasso | M | 51 | 4 years | |
| Peter T. Slover | M | 49 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 8 years |
| Ronald M. Lindsay | M | 76 | 13 years | |
| Christine Anna White | M | 72 | 13 years | |
| Heidi Henson | F | 58 | 4 years | |
| James Basta | M | 58 | - | |
| Antonio Gualberto | M | 59 | 6 years | |
| Bryan Williams | M | 74 | 7 years | |
| Ofir Moreno | M | - | 12 years | |
| Raymond Huggenberger | M | 65 |
Sunrise Medical, Inc.
| 10 years |
| Leah Cann | F | 63 | 7 years | |
| Kevan E. Clemens | M | 80 | 7 years | |
| Robert Hoffman | M | 58 | 6 years | |
| Harry F. Hixson | M | 84 | 12 years | |
| Larry C. Buckelew | M | 70 |
Sunrise Medical, Inc.
| 10 years |
| Kirsten Flowers | F | 49 | 3 years | |
| Gabriela Rossi | F | - | 1 years | |
| Sudipto Sur | M | - | 3 years | |
| Mathias Ehrich | M | - | - | |
| Kelly Powell | F | - | - | |
| Blake Tomkinson | M | - | 4 years | |
| Wendy J. Levin | M | - | - | |
| Charlie Rodi | M | - | 3 years | |
| Robert D. Mass | M | 70 | 11 years | |
| John Farnam | M | - | 1 years | |
| Todd Butler | M | - | 2 years | |
| Karen Potts | M | 61 | - | |
| Bridget Martell | M | 58 | 3 years | |
| Rolf Classon | M | 79 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | 6 years |
| Carmine Stengone | M | 48 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 2 years |
| Steven Holtzman | M | 70 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 7 years |
| Paul John Nestel | M | - | 9 years | |
| Tristan B. Orpin | M | 58 | 3 years | |
| Michael J. Terry | M | 69 | 2 years | |
| Mark E. Spring | M | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Clarke Neumann | M | 60 | 15 years | |
| Karsten Schmidt | M | 62 | - | |
| Dereck A. Tatman | M | 51 | - | |
| Helmut Schühsler | M | 65 | 7 years | |
| Frederick A. Fletcher | M | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Jay Lichter | M | 62 | - | |
| Michael V. Swanson | M | 69 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | 8 years |
| Benjamin M. Anderson-Ray | M | 69 |
Sunrise Medical, Inc.
| - |
| Robin M. Jackman | M | 54 | - | |
| Douglas Williams | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 5 years |
| Philip A. Johnston | M | - | 10 years | |
| Shishir Sinha | M | 57 | 3 years | |
| Hua Gong | M | 57 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Pete de Spain
- Personal Network
